See more : Achari Ventures Holdings Corp. I (AVHI) Income Statement Analysis – Financial Results
Complete financial analysis of Vista Pharmaceuticals Limited (VISTAPH.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Vista Pharmaceuticals Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Liaoning Oxiranchem,Inc. (300082.SZ) Income Statement Analysis – Financial Results
- Population Health Investment Co., Inc. (PHICW) Income Statement Analysis – Financial Results
- Groupe Guillin S.A. (0D1X.L) Income Statement Analysis – Financial Results
- South Shore Holdings Limited (LOUIF) Income Statement Analysis – Financial Results
- Sphere Resources Inc. (SPHUF) Income Statement Analysis – Financial Results
Vista Pharmaceuticals Limited (VISTAPH.BO)
About Vista Pharmaceuticals Limited
Vista Pharmaceuticals Ltd. engages in the manufacture and market of pharmaceutical products. It offers over the counter and prescription generic drug products consisting of tablets, capsules, and liquids covering different therapeutic categories. The company was founded by Dhananjaya Alli on January 25, 1991 and is headquartered in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 102.88M | 10.04M | 3.95M | 12.66M | 227.59M | 310.73M | 282.17M | 241.82M | 153.80M | 137.47M | 83.02M | 74.69M | 36.22M | 56.74M | 8.01M | 18.23M |
| Cost of Revenue | 92.86M | 31.94M | 6.11M | 7.72M | 242.28M | 255.67M | 163.41M | 162.18M | 106.98M | 89.32M | 58.75M | 52.37M | 33.22M | 43.80M | 4.52M | 11.37M |
| Gross Profit | 10.02M | -21.91M | -2.17M | 4.95M | -14.69M | 55.06M | 118.76M | 79.64M | 46.82M | 48.14M | 24.27M | 22.32M | 3.00M | 12.94M | 3.50M | 6.86M |
| Gross Profit Ratio | 9.74% | -218.24% | -54.92% | 39.08% | -6.46% | 17.72% | 42.09% | 32.94% | 30.44% | 35.02% | 29.23% | 29.89% | 8.29% | 22.81% | 43.62% | 37.61% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.22M | 24.21M | 223.86K | 284.76K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 19.03M | 1.92M | 1.01M | 920.00K | 2.06M | 2.98M | 4.47M | 1.53M | 725.67K | 14.16M | 5.82M | 7.53M | 4.97M | 3.93M | 0.00 | 0.00 |
| Selling & Marketing | 1.14M | 100.00K | 656.00K | 77.00K | 33.00K | 1.19M | 13.53M | 16.91M | 64.81K | 88.71K | 1.41M | 2.19M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 20.17M | 2.02M | 1.66M | 997.00K | 2.09M | 4.17M | 18.00M | 18.44M | 790.48K | 14.16M | 5.82M | 7.53M | 4.97M | 3.93M | 0.00 | 0.00 |
| Other Expenses | 0.00 | 2.86M | 1.66M | 948.00K | 35.90M | 16.24M | 1.19M | 491.00K | -872.28K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 20.17M | 16.90M | 16.10M | 29.52M | 46.75M | 50.12M | 54.51M | 49.99M | 29.51M | 31.54M | 19.80M | 20.62M | 18.36M | 15.83M | 16.66M | 17.00M |
| Cost & Expenses | 113.02M | 48.85M | 22.21M | 37.24M | 289.03M | 305.79M | 217.91M | 212.17M | 136.49M | 120.86M | 78.55M | 72.99M | 51.58M | 59.63M | 21.18M | 28.38M |
| Interest Income | 1.39M | 1.29M | 1.66M | 1.00M | 0.00 | 21.00K | 515.00K | 83.00K | 68.95K | 77.88K | 297.32K | 84.15K | 70.48K | 52.80K | 0.00 | 32.00K |
| Interest Expense | 12.37M | 13.10M | 8.98M | 15.45M | 13.64M | 15.62M | 14.48M | 8.08M | 7.54M | 3.84M | 30.86K | 77.78K | 119.33K | 91.76K | 0.00 | 0.00 |
| Depreciation & Amortization | 7.20M | 6.18M | 6.16M | 7.28M | 13.46M | 13.64M | 37.56M | 19.39M | 10.15M | 10.46M | 774.39K | 6.45M | 6.37M | 5.19M | 2.68M | 2.65M |
| EBITDA | -32.38M | -40.45M | -11.02M | -15.35M | -10.50M | 18.58M | 81.58M | 40.38M | 26.15M | 27.07M | 12.48M | 8.15M | -9.04M | 2.31M | -10.49M | -7.46M |
| EBITDA Ratio | -31.47% | -331.62% | -279.73% | -121.51% | -5.39% | 15.11% | 28.46% | 16.42% | 16.95% | 19.54% | 15.03% | 10.91% | -24.83% | 4.07% | -130.83% | -40.93% |
| Operating Income | -10.15M | -46.29M | -18.27M | -24.57M | -58.19M | 4.94M | 40.05M | 11.26M | 8.38M | 12.57M | 4.73M | 1.70M | -15.41M | -2.92M | -13.16M | -10.11M |
| Operating Income Ratio | -9.86% | -461.20% | -462.95% | -194.05% | -25.57% | 1.59% | 14.19% | 4.66% | 5.45% | 9.14% | 5.70% | 2.28% | -42.54% | -5.15% | -164.23% | -55.48% |
| Total Other Income/Expenses | -41.63M | -12.47M | -7.91M | -30.20M | 18.83M | -23.68M | -11.78M | -8.19M | -18.14M | -14.50M | -7.67M | 6.38K | 1.00 | -38.96K | 0.00 | 0.00 |
| Income Before Tax | -51.77M | -58.76M | -26.18M | -38.11M | -39.36M | 11.47M | 28.27M | 12.23M | 8.38M | 12.57M | 4.73M | 1.70M | -15.41M | -2.92M | -13.16M | -10.11M |
| Income Before Tax Ratio | -50.33% | -585.46% | -663.36% | -300.96% | -17.29% | 3.69% | 10.02% | 5.06% | 5.45% | 9.14% | 5.70% | 2.28% | -42.54% | -5.15% | -164.23% | -55.48% |
| Income Tax Expense | -6.65M | -2.14M | -17.29M | -18.03M | -2.59M | 2.08M | 6.41M | -250.00K | 641.83K | -1.05M | 64.40K | 898.80K | 1.22M | 38.96K | 0.00 | 0.00 |
| Net Income | -45.12M | -56.62M | -8.89M | -20.09M | -36.77M | 9.39M | 21.87M | 12.48M | 7.74M | 13.62M | 4.67M | 805.35K | -16.63M | -2.92M | -13.16M | -10.11M |
| Net Income Ratio | -43.86% | -564.11% | -225.19% | -158.61% | -16.16% | 3.02% | 7.75% | 5.16% | 5.03% | 9.91% | 5.62% | 1.08% | -45.91% | -5.15% | -164.23% | -55.48% |
| EPS | -0.96 | -1.54 | -0.24 | -0.58 | -1.21 | 0.31 | 0.76 | 0.46 | 0.31 | 0.54 | 0.31 | 0.05 | -1.11 | -0.19 | -0.87 | -0.67 |
| EPS Diluted | -0.96 | -1.54 | -0.24 | -0.58 | -1.21 | 0.30 | 0.73 | 0.46 | 0.31 | 0.54 | 0.31 | 0.05 | -1.11 | -0.19 | -0.87 | -0.67 |
| Weighted Avg Shares Out | 46.90M | 36.83M | 36.79M | 34.65M | 30.37M | 30.16M | 28.92M | 27.23M | 25.00M | 25.00M | 15.00M | 15.00M | 15.00M | 15.00M | 15.13M | 15.10M |
| Weighted Avg Shares Out (Dil) | 46.90M | 36.83M | 36.79M | 34.65M | 30.37M | 30.88M | 29.92M | 27.23M | 25.00M | 25.00M | 15.00M | 15.00M | 15.00M | 15.00M | 15.13M | 15.10M |
No news found for: VISTAPH.BO
Source: https://incomestatements.info
Category: Stock Reports